Chikungunya Virus
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years (NCT05349617) | Bavarian Nordic | 2022-05-12 |
| A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine (NCT05065983) | Bavarian Nordic | 2021-10-11 |
| A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) (NCT05072080) | Bavarian Nordic | 2021-09-29 |
| Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants (NCT03325075) | ModernaTX, Inc. | 2017-07-19 |
| A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components (NCT02305732) | Cerus Corporation | 2015-03-01 |
| CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease (NCT00391313) | Assistance Publique Hopitaux De Marseille | 2006-05-01 |
Track Chikungunya Virus automatically
Every clearance here is in the API, with alerts when new ones post.